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Abstract
Background: Cardiac rehabilitation following myocardial infarction reduces subsequent mortality,
but uptake and adherence to rehabilitation programmes remains poor, particularly among women,
the elderly and ethnic minority groups. Evidence of the effectiveness of home-based cardiac
rehabilitation remains limited. This trial evaluates the effectiveness and cost-effectiveness of home-
based compared to hospital-based cardiac rehabilitation.
Methods/design: A pragmatic randomised controlled trial of home-based compared with
hospital-based cardiac rehabilitation in four hospitals serving a multi-ethnic inner city population in
the United Kingdom was designed. The home programme is nurse-facilitated, manual-based using
the Heart Manual. The hospital programmes offer comprehensive cardiac rehabilitation in an out-
patient setting.
Patients: We will randomise 650 adult, English or Punjabi-speaking patients of low-medium risk
following myocardial infarction, coronary angioplasty or coronary artery bypass graft who have
been referred for cardiac rehabilitation.
Main outcome measures: Serum cholesterol, smoking cessation, blood pressure, Hospital
Anxiety and Depression Score, distance walked on Shuttle walk-test measured at 6, 12 and 24
months. Adherence to the programmes will be estimated using patient self-reports of activity.
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BMC Cardiovascular Disorders 2003, 3 http://www.biomedcentral.com/1471-2261/3/10In-depth interviews with non-attendees and non-adherers will ascertain patient views and the
acceptability of the programmes and provide insights about non-attendance and aims to generate
a theory of attendance at cardiac rehabilitation. The economic analysis will measure National
Health Service costs using resource inputs. Patient costs will be established from the qualitative
research, in particular how they affect adherence.
Discussion: More data are needed on the role of home-based versus hospital-based cardiac
rehabilitation for patients following myocardial infarction and revascularisation, which would be
provided by the Birmingham Rehabilitation Uptake Maximisation Study (BRUM) study and has
implications for the clinical management of these patients. A novel feature of this study is the
inclusion of non-English Punjabi speakers.
Background
Cardiac rehabilitation services aim to facilitate physical,
psychological and emotional recovery and to enable
patients to achieve and maintain better health[1]. This is
achieved through exercise, patient education and advice,
relaxation, drug therapy, and specific help for patients
with psychological sequelae. [2–4]
The majority of cardiac rehabilitation programmes in the
UK are hospital-based combined programmes including
exercise, psychological and educational interventions [2–
4]. Meta-analyses of the effectiveness of combined pro-
grammes suggest that they can achieve a reduction in car-
diac mortality of 20–26% over a 1–3 year time frame [5–
7]. Psychological and educational interventions, includ-
ing patient education, counselling and behavioural inter-
ventions have been addressed in two meta-analyses [8–
10] and systematic reviews [11,12]. These have shown
that cardiac rehabilitation can improve blood pressure
and serum cholesterol levels [8–10] psychological well-
being [9,11] and patient knowledge[12] and estimated a
relative reduction in recurrent non-fatal cardiac events of
46% [9], in cardiac mortality by 34% [10] and mortality
of 19% [8].
Relatively few studies have evaluated the effectiveness of
cardiac rehabilitation following revascularisation and
there is still insufficient evidence about the effects of car-
diac rehabilitation on survival. Cardiac rehabilitation
rehabilitation programmes have reported some benefits
in aerobic capacity [13] a reduction of smoking and lower
blood pressure [14,15], lower anxiety scores[16] and
improvement in lipoprotein patterns [17].
Home-based cardiac rehabilitation
Trials comparing home-based cardiac rehabilitation pro-
grammes to usual care (controls) have reported signifi-
cantly greater improvements in exercise capacity[18,19],
systolic blood pressure [20] and lower anxiety [21] in the
patients participating in home rehabilitation compared to
the controls at follow-up. Six randomised controlled trials
comparing home-based to supervised centre-based car-
diac rehabilitation programmes have been pub-
lished[18,19,22–25]. These studies report similar
improvements in exercise capacity, systolic blood pressure
or serum cholesterol at follow-up between the home and
centre-based groups. A home-based programme using the
Heart Manual (West Lothian Health Care Trust, Scotland)
reported significantly reduced hospital admissions in the
home-based group during the first 6-months of follow-up
compared to patients receiving usual care [18] and in a
cardiac rehabilitation programme following CABG the
patients in the home-based arm reported a significantly
improved quality of life compared to patients attending a
hospital programme [25].
The trials suffer from being an exercise-only rather than
comprehensive intervention [23,26,27], have small num-
bers [21,28], and a high proportion of patients were
excluded on health grounds [23,26], sex and age [23,26]
Lewin's Heart Manual, which was developed for use at
home, has been evaluated against control groups [23,26],
and hospital-based rehabilitation in an unpublished
study (Jennifer Bell, personal communication). The latter
study reports no difference in the primary outcome meas-
ure of symptom limited exercise time between hospital
and home groups during 1 year follow-up. This trial
excluded patients aged 65 years or greater and took place
in the south of England. Contrary to some concerns,
home-based exercise programmes have not reported an
increased risk of sudden death, but the trials have not
been large, and there is insufficient evidence in this area
[23,24]
Uptake and adherence to cardiac rehabilitation
It is clear that many people who would benefit from car-
diac rehabilitation are not receiving it. This is due to both
service and patient factors. Uptake rates for cardiac reha-
bilitation have been reported to range from 15–59%
[29,30] Many services concentrate on relatively low risk,
white middle aged patients, whilst women and the elderly
are less likely to be invited [29,31]Page 2 of 11
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erature about uptake in people from ethnic minority
groups in the UK, although anecdotal data from those
programmes serving large ethnic minority populations in
Birmingham suggest that they are under-represented, par-
ticularly the women. A study in the USA reported a higher
drop-out rate of black women from a cardiac rehabilita-
tion programme compared to white women, despite a
greater prevalence of risk factors in the black women [32].
Poor uptake is also related to service factors, such as the
availability and accessibility of a programme [33], the
strength of a physician's recommendation to attend
[31,34] and treatment by a general physician, rather than
a cardiologist [29]. Patient factors include the reported
feeling amongst the elderly and women that they will be
out of place [35] and beliefs about whether their illness
was amenable to cure or control [36]. Socio-demographic
factors such as deprivation [29], level of education [37]
and spouse involvement [38] are significant predictors of
uptake.
Of those patients who do attend hospital cardiac rehabil-
itation the drop-out rates from exercise programmes range
from 20% in the first three months to 50% at 6 months to
a year[39]. Dropout rates have been reported to be higher
in high intensity exercise programmes and poorly organ-
ised programmes. Smokers, patients who have had more
that one MI [39–41], and women are more likely to drop
out [42]. Qualitative insights are limited [43–45], but sug-
gest that patients' behaviour results from confusion about
the aims, content and structure of rehabilitation pro-
grammes, their own beliefs or the information given by
health professional as to the 'seriousness' of their cardiac
event. Reasons for non-adherence to cardiac rehabilita-
tion given by Asian patients include not having been for-
mally invited to rejoin a programme if they missed a
session and difficulties in contacting telephone help-
lines[46].
There is little research looking at ways of increasing uptake
and adherence to cardiac rehabilitation programmes.
Physical difficulties, such as difficulty parking and lack of
spouse support have been cited as reasons for dropping
out of an exercise programme [33]. Qualitative interviews
were carried out with survivors of myocardial infarction in
Scotland and identified 38% who did not want to attend
a group for rehabilitation [35]. Thus, there is clearly a
need to evaluate programmes that might be more inclu-
sive, achieve higher uptake rates in certain groups, and
minimise subsequent dropouts amongst those who have
started a rehabilitation programme. It is possible that
home programmes might be more effective as a result of
greater participation or 'uptake'.
Cost and cost-effectiveness of cardiac rehabilitation
Insufficient evidence relevant to the UK exists as to the
cost-effectiveness of cardiac rehabilitation. A survey of
program costs in the UK has been reported [47]. A cost-
effectiveness and cost-utility analysis in America [48] was
based on one meta-analysis [6], and the costs have been
recalculated to reflect UK costs[49]. The UK results suggest
a cost per life year gained at three years of €15,700 and a
cost per QALY of €6,900. A randomised controlled trial
based in Italy reported lower direct costs in the home pro-
gramme, as a result of lower programme costs and
reduced health care utilisation [19].
What is known about current provision?
A number of recent surveys of cardiac rehabilitation pro-
grammes in the UK have highlighted deficiencies [2,3,50].
Practice in Scotland was found to fall short of that advo-
cated in guidelines and was usually more limited in its
provision than had shown benefits in randomised con-
trolled trials [3]. Practice was generally found not to be
individually tailored to patients and many patients were
excluded due to age or illness [2,50] The UK National
Service Framework for Coronary Heart Disease sets the
goal for all patients discharged from hospital with a pri-
mary diagnosis of acute myocardial infarction or revascu-
larisation to be offered appropriate cardiac rehabilitation
and sets targets for behavioural change at one year in these
patients.
Methods/Design
BRUM is a randomised controlled trial (RCT) of home-
based versus hospital-based cardiac rehabilitation in a
multi-ethnic population, funded by the NHS Research
and Development Programme. The primary research
question seeks the relative effectiveness and cost-effective-
ness, of home-based compared with hospital-based car-
diac rehabilitation, and the reasons for non-participation.
To answer these questions BRUM will determine whether
there are differences at 6 months, 1 and 2 years following
hospital- and home-based cardiac rehabilitation in objec-
tive cardiac risk factors; patient reported uptake and
adherence. It will also explore whether these differ
between patient groups (the elderly, women and patients
from ethnic minority groups). Secondly, the relative costs
of hospital- and home-based cardiac rehabilitation from
both the patients' and NHS perspectives will be deter-
mined, as well as qualitative insights into the reasons for
non-participation in the cardiac rehabilitation pro-
grammes. Lastly, BRUM will ascertain whether there are
differences in cardiac clinical events (MI/death from car-
diac cause) at 2 years following hospital- and home-based
cardiac rehabilitation.Page 3 of 11
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Inclusion and exclusion criteria are described in table 1.
The four hospitals from which patients are recruited are in
the West-Midlands in the U.K. Three serve deprived mixed
race inner city populations, up to 25% from minority eth-
nic groups, mainly South Asians and Afro-Caribbeans.
Given the high incidence of coronary heart disease in peo-
ple of South Asian origin, and the low uptake of cardiac
rehabilitation in people living in deprived circumstances
[29], this makes it an ideal population in which to study
uptake of cardiac rehabilitation. In addition, work done
locally has identified that South Asians are less likely to
take exercise, and have a lower awareness of what consti-
tutes a healthy diet than the white population [51,52].
The study has three parts. Firstly, a pragmatic randomised
controlled trial comparing the clinical effectiveness of
home- and hospital-based strategies. Secondly, the results
of this will be used to inform an economic model, which
will explore the generalisability of the results and to com-
pare these with other coronary heart disease interven-
tions. Thirdly, a qualitative study running alongside the
trial, to gain insights into reasons for poor uptake and lack
of adherence.
Randomised controlled trial design
The trial is a pragmatic, two arm randomised controlled
trial of patients following MI or revascularisation, using
individual patient randomisation. Patients are identified
by the rehabilitation nurses following hospital admission
for MI or PTCA. Patients following CABG are normally
followed-up and referred for rehabilitation at their hospi-
tal of origin. All eligible patients will be informed about
the study prior to hospital discharge and asked if they
would consent to randomisation. For patients who do not
speak English, tape recordings of the patient information
leaflet are available, and Punjabi speaking nurses are
available to answer questions. Patients are not excluded
from the study on the grounds of age.
Baseline data are collected prior to randomisation. These
include demographic details, disease history and baseline
measures of the outcome data. Data for Killip Class and
Peel Index Scores[53,54]. (measures of severity of infarc-
tion), or numbers of vessels stented or bypassed are col-
lected to check comparability in risk between the groups
at baseline.
Patients who consent to randomisation are randomised
centrally by computer on an individual basis with stratifi-
cation by (i) original diagnosis (MI/revascularisation) (ii)
age/sex, (iii) ethnicity (Caucasian/Asian/Other) and (iv)
hospital of recruitment, using the method of
minimisation.
• In one arm patients are invited to the hospital's usual
cardiac rehabilitation programme;
• In the second arm patients are invited to undertake a
home-based cardiac rehabilitation programme.
The trial design is summarised in Figure 1. Patients who
refuse randomisation are offered their respective hospi-
tal's usual rehabilitation package.
What are the planned trial interventions?
Both rehabilitation programmes include exercise, relaxa-
tion, education and life-style counselling, with referral for
psychological treatments as indicated. All patients are
seen prior to hospital discharge and provided with infor-
mation about their condition and counselling about risk
factor modification.
• Hospital-based cardiac rehabilitation
Table 1: Inclusion and exclusion criteria for BRUM study
Inclusion criteria Exclusion criteria (applied by a cardiologist)
Diagnosis within previous 3 months of a first or subsequent myocardial 
infarction (MI)
Case-note reported dementia
Diagnosis within previous 3 months of a first or subsequent 
percutaneous transluminal coronary angioplasty (PTCA)
Unstable angina
Diagnosis within previous 3 months of a first or subsequent coronary 
artery bypass graft (CABG)
Cardiac arrhythmias
English or Punjabi speakers Severe heart failure
Sight defects of sufficient severity to prevent the reading of the Heart 
Manual
Severe hearing impairmentPage 4 of 11
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with the guidance in the National Service Framework
(NSF) for coronary heart disease[55]. All hospitals have a
protocol for cardiac rehabilitation, but as there are stylistic
differences in patient management all analyses will be
stratified by hospital.
The four hospitals provide comprehensive cardiac reha-
bilitation programmes consisting of risk factor counsel-
ling, relaxation, and supervised exercise sessions for 6–12
weeks once to twice weekly.
• Home-based cardiac rehabilitation
This consists of a manual, home visits and telephone con-
tact. Patients who have had an MI are discharged home
with 'The Heart Manual' (West Lothian Health Care
Trust). Those who have had a revascularisation have a
similar Heart Manual designed for this patient group. The
Heart Manual is a facilitated home-based programme for
the first 6 weeks following MI or revascularisation and
includes education, a home-based exercise programme
and a tape-based relaxation and stress management pro-
gramme. It also has accompanying tapes in ethnic minor-
ity languages for patients who are unable to read English.
Information about how to contact their rehabilitation
nurse will be provided. Home visits take place at 1–2
weeks and 6 and 12 weeks, and telephone contact at 3
weeks during which the rehabilitation nurse discusses the
contents of the manual with the patient and partner or
other relative, and sets individual objectives with the
patient with respect to smoking cessation, diet and exer-
cise. Patients with no telephone have home visits instead
of telephone contacts. Patients who speak Punjabi and
have an insufficient command of English have contact
with a rehabilitation nurse who speaks Punjabi. An audi-
otape in Punjabi accompanies the manual in patients
with a limited command of English (as many non-English
speakers of this age-group are also illiterate). Patients in
Study outlineFigure 1
Study outline. CCU: coronary care unit; MI: myocardial infarction; PTCA: percutaneous transluminal coronary angioplasty; 
CABG: coronary artery bypass graft.
Collection of baseline data - Randomisation stratified by sex, ethnicity, diagnosis & hospital 
Hospital rehabilitation programme: 
Supervised exercise, relaxation, risk factor assessment 
and life-style counselling 
Home rehabilitation programme: 
The Heart Manual with home visits at 10 days, 6 weeks 
and 12 weeks, plus telephone support. 
Follow-up at 6, 12 & 24 months for clinical endpoints 
MI / PTCA CABG 
Identified in hospital Referral from surgical centre to participating hospitals   
Agree to randomisation 
Hand over to primary care team or phase IV rehabilitation Page 5 of 11
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the modified Godin questionnaire at 6, 9 and 12 weeks to
record activity undertaken in the previous week. Hospital-
based rehabilitation runs for 9–12 weeks. The Heart Man-
ual covers the first 6 weeks post-event, but we have
extended contact with patients in the home programme
until 3–4 months to coincide with the end of the hospital
programme.
Recruitment will take place over 18 months. Follow-up
will take place by postal questionnaire and clinical assess-
ment at 6 months, 1 year and 2 years. Patient records will
be flagged by the ONS to identify deaths from cardiac
causes.
Outcome measures
The primary outcome measures include: (i) cardiac risk
factors; (ii) adherence measures. Secondary outcome
measures are for (iii) self-reported behaviour, symptoms
and secondary preventive medication; (iv) quality of life;
(v) death and other cardiac events. Because of compara-
bility differences and the rarity of death and infarction,
cardiac risk factors are given primacy (Details are given in
table 2).
If a cardiac rehabilitation programme has a high patient
uptake and adherence and is effective, it will lead to reduc-
tions in risk factors, which in turn should translate to a
reduction in cardiac events[40,56–65]. At 1 year mortality
rates are low (6% in Jolly 1999 [66]) and it is unlikely that
we would see a reduction in cardiac events. It is also pos-
sible that revascularisation rates could be associated with
participation in a particular rehabilitation programme.
Since the interventions are multi-factorial and aims are
broad, the use of a number of cardiac risk factors as pri-
mary outcome measures at 6 months and 1 and 2 years
follow-up are justified.
Patient uptake and adherence to the programmes are of
primary interest. However, there will be difficulties in
obtaining unbiased measures of these, as attendance at a
hospital programme cannot be equivalently compared to
acceptance of a home visit. Patient completed activity
questionnaires (modified Godin at 6, 9 and 12 weeks) are
used for both groups to provide a comparison of activity
and thus of adherence to the programmes.
To reduce the potential for bias in measuring outcomes
clinical follow-up will be undertaken by an individual
who has not provided the rehabilitation support.
Sample size
Assuming a conservative estimate of 30% attrition at 1
year (a lower attrition would increase the power of the
study) due to death and loss to follow-up (15% in Jolly
1999 [66]), a sample size of 650 patients (450 evaluable
at 1 year) would have 90% power, at the 5% significance
level, to detect the differences tabulated (table 3) (popu-
lation standard deviations estimated from Jolly 1999
[66]).
Statistical analysis
All data will be analysed by intention to treat. All analyses
will be stratified by centre. Comparisons between the pri-
mary outcome measures of cardiac risk factors will be
made at three separate time points, 6 months, one year
and two years, to assess both short and longer-term effects
of the two rehabilitation strategies.
Table 2: Outcome measures of BRUM study
Primary outcome measures Secondary outcome measures
Serum cholesterol BMI (Body Mass Index)
Blood pressure (assessed according to British Hypertension Society 
Guidelines)
Self-reported diet
Exercise capacity as assessed by the shuttle-walk test (the association 
with VO2 max has been validated in patients with heart failure and 
following CABG [76])
Self-reported exercise (Godin[77])
Psychological morbidity: Hospital Anxiety and Depression Scale[78] 
(Asian patients will complete a translated version)
Health care utilisation (primary and secondary care and phase IV 
rehabilitation)
Cotinine validated smoking cessation Cardiac symptoms (angina and shortness of breath)
Use of secondary preventive medication
Adherence Quality of life (Euroqol EQ5D)
Self-reported physical activity at 6, 9 and 12 weeks Death and cardiac events
The Global Mood Scale to English speaking patients (at 6 months only)
Quality of life (Short Form-12) (at 6 months only)
Patient satisfaction with the programmes (at 6 months only)Page 6 of 11
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(serum cholesterol, systolic blood pressure, exercise
capacity, HADS anxiety and depression), differences in
means between the two groups will be investigated. Base-
line measurements for exercise capacity will not be avail-
able as patients are randomised approximately 4 days
post-MI and the day after PTCA which is too early to
undertake an exercise test. As the sample is large and ran-
domised we would not expect baseline differences
between the groups. For the other measures, analysis of
covariance will be used to take into account the baseline
measurements for each patient. When baseline informa-
tion is available this provides a more precise estimate of
the treatment effect than either raw outcomes or change
scores[67]. Differences in smoking cessation will be
assessed amongst those who were smokers at baseline
using the Cochran-Mantel-Haenszel2 test for a difference
in proportions; confidence intervals will be calculated
using the formula due to Cochran.
Secondary analyses will be conducted for each primary
outcome measure adjusting for diagnosis (MI/revascular-
isation), age, sex and ethnicity, as well as centre (logistic
regression will be used to provide adjusted analyses for
smoking cessation). Interaction terms between these fac-
tors and rehabilitation setting will be included to investi-
gate possible differences in treatment effect between
subgroups of patients. Although the power to detect mod-
est interactions will be low, we are primarily interested in
investigating the possibility of large interactions which are
qualitative rather than quantitative in nature, that is, the
possibility that the direction of treatment effects may vary
between groups of patients.
Throughout the analysis emphasis will be placed on esti-
mation rather than hypothesis testing. Where hypothesis
tests are carried out, these will be at the 5% level for pri-
mary outcome variables, and at the 1% level for interac-
tion terms. Although a strict Bonferroni adjustment for
multiple testing would suggest use of somewhat more
conservative significance levels (1% for primary out-
comes), this adjustment is too conservative when out-
comes are positively correlated, as they will be in this trial.
Although alternative methods of adjustment are available,
the performance of these methods depends heavily on the
underlying data structure[68]. Multivariate methods,
which model all outcomes simultaneously and provide a
single 'global' test of significance, are available. However,
univariate methods involve fewer distributional assump-
tions and are more straightforward to interpret. Further-
more, in this trial we are investigating what has been
termed 'multiple univariate hypotheses' rather than a true
(single) multivariate hypothesis; the univariate methods
outlined above are thus more appropriate[69].
Economic Evaluation
Costs will be assessed from two perspectives: that of the
NHS and societally. NHS costs will be based on resource
inputs costed up to include labour and overhead costs.
Societal costs will be ascertained qualitatively, with the
particular emphasis of describing whether the costs to an
individual of participating in a cardiac rehabilitation pro-
gramme is a factor affecting the uptake of and adherence
to that programme. If outcomes differ between the
models, a cost effectiveness evaluation will explore incre-
mental cost effectiveness using the primary measures
noted above, clinical risk factors and uptake. If clinical
outcomes do not differ a cost minimisation analysis is
appropriate for cost per patient. The incremental effects
and costs of any increased take-up in one arm will be
analysed.
Comparing the costs of the existing hospital services with
the home based service requires the use of identical meth-
Table 3: Size of differences detected by sample size
Endpoint Difference Assumptions Precision of estimate
95% 99%
Mean serum cholesterol/ mMol/L 0.4 Sda = 1.3 ± 0.24 ± 0.32
Systolic blood pressure/ mmHg 6 sd = 21 ± 3.9 ± 5.1
Shuttle-walk test/10 metre shuttles 6 sd=b20 or sd = * 40 ± 3.7 ± 7.4 ± 4.9 ± 9.7
HADSc anxiety 1.5 sd = 4.5 ± 0.83 ± 1.1
HADSc depression 1.5 sd = 4.0 ± 0.74 ± 0.97
Smoking cessation 20% (Jolly [66]) 45% smokers at baseline (effective sample 
size approx 200) 50% give up in hospital-
based group
9%, 33% 5%, 37%
a Standard deviation b SD 19 reported in Keell et al [76], but this study was in 50 male patients with established left ventricular dysfunction (mean 38, 
range 4–102). No other selection criteria stated, but may have been relatively highly selected (apart from sex) and thus likely to be a substantial 
underestimate of the standard deviation for our population. Further estimates are given assuming a standard deviation for our population of 40. The 
true value is likely to lie somewhere between these extremes c Hospital Anxiety and Depression scalePage 7 of 11
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estimates might apply in practice. Bottom-up costing will
be employed, based on detailed data collection of
resources used, mainly staff inputs by duration and type.
Any knock-on effects on use of other services would be
identified and costed. The estimation of non-staff costs in
each programme (overheads, administration, accommo-
dation and travel) will also be based on observed resource
use but also explored in a costing model. The model will
enable the cost impact of changes in levels of service and
in location to be quantified. The generalisability of the
results will be explored by locating the costs in a national
context by a national survey of costs of all English cardiac
rehabilitation programmes.
Qualitative Study
The qualitative part of the study seeks insights into the
reasons for non-participation or non-adherence by
patients in the cardiac rehabilitation research pro-
grammes with the objective of generating a theory of
adherence to cardiac rehabilitation. Qualitative
methodologies offer the most appropriate way to elicit
their reasons for non-participation as they enable people's
beliefs, knowledge and the meanings they ascribe to their
health experiences and behaviours to be explored and
understood[70]. The methods of grounded theory will be
used[71,72] to guide sampling, data collection and data
analysis. The qualitative interviewing technique of semi-
structured interview[73] will be used, which is firmly
established in the social sciences and increasingly valued
in health and medical research.
Participants and sampling
From the initial sample of all study participants details
will be kept of those (i) who decline to commence a reha-
bilitation programme and (ii) those who commence but
do not adhere. Patients in the home-based arm will be
defined as declining the programme if they do not accept
any home visits. They will be defined as non-adhering if,
in the opinion of the cardiac rehabilitation nurse, they do
not read the Heart Manual or use the tapes or attempt the
exercise programme or cease participation during the 12
week programme. Patients in the hospital arm will be
defined as non-adhering if they do not complete the reha-
bilitation programme for reasons other than ill-health.
Within each of these two categories (declining and non-
adhering patients) we will seek a purposive sample of 10
patients from each of four groups (women, the elderly,
minority ethnic group patients, younger white men) for
initial sampling (40 patients in total). Patients will be ran-
domly selected from the lists and contacted for interview
until ten have been interviewed. This will be followed by
seeking a further theoretical sample[72] within each
group with selection of patients guided by emerging data
analysis in order to extend and challenge earlier data and
interpretation, and test the integrity and credibility of the
developing analysis. This theoretical sample may include
patients with particular experiences that it becomes
important to seek as the analysis develops. It is anticipated
that up to 10 further respondents in each of the four
groups may be sought in this way (maximum 80 partici-
pants), before interviewing is no longer generating new
concepts and is discontinued i.e. theoretical
saturation[71].
Methods and analysis
Data from patients will be collected by confidential, face-
to-face interview[73] in patients' own homes, using an
interview topic prompt. The interview topic prompt will
be developed using existing knowledge from the literature
to derive initial topic areas, and then modified and refined
by interviewing in a pilot phase of the study a sample of
patients who had not commenced or adhered to a
previous cardiac rehabilitation programme at one of the
study hospitals. The interviews will follow broad topic
areas based upon the study objectives, but encourage
respondents to discuss their perceptions and experiences
freely. Their recent cardiac event and arrangements for
rehabilitation will be specifically focussed on and
explored in depth. The acceptability of rehabilitation pro-
grammes and perceptions of these and any preference
they initially had for the hospital or home programme
will be explored. Interviews with patients who wish to be
interviewed in their own language will be carried out
either by a bilingual researcher or a researcher assisted by
bilingual interpreters with appropriate language skills fol-
lowing processes for good practice[72]
All interviews will be audio taped and transcribed into
English, using commercial transcribing services where
appropriate. Transcriptions will be read and checked for
accuracy by the research fellow and the text then entered
into a computerised database using the Atlas ti software
package for qualitative data analysis.
Data analysis will acknowledge the impact of the use of
interpreters where appropriate[74]. Constant comparative
analysis will be used to interpret the data[75]. To maxim-
ise theoretical sensitivity[72], researchers from different
disciplinary and professional backgrounds will contribute
to the development of the analysis and conceptual frame-
work. Coding processes[72] will be aided by application
of the Atlas ti software in identifying emerging key catego-
ries and concepts from the data. These will be compared
across the different interview data sources and established
concepts in the literature. Data collection and analysis will
be iterative, occurring as data collection in the interviews
proceeds with new data being used to challenge, assess or
confirm the emerging analysis. Concepts identified will bePage 8 of 11
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tion of findings.
Discussion
The BRUM trial seeks to recruit patients from an inner city
multi-cultural population and to include patients who are
unable to speak or read English well, but do speak Punjabi
(the most frequently spoken minority language locally).
Since literacy rates are low in the non-English speaking
population this has required a taped version of the Heart
Manual in Punjabi and the need for the primary outcome
measurement tools to be available in Punjabi. As a result,
a translation and validation study of a Punjabi version of
the Hospital Anxiety and Depression Scales (HADS) had
to be undertaken prior to the start of the study. The final
results of the study will not be available before 2006.
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